One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement

One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement

Toshiaki Hirakata,1,2,* Kaoru Fujinami,1,3,4,* Ken Watanabe,5 Mariko Sasaki,1,3,6 Toru Noda,1,5 Kunihiko Akiyama1,5 1Laboratory of Visual Physiology, Division for Vision Research, National Institute of Sensory Organs, National Hospital Organization, Tokyo Medical Center, Tokyo, Japan; 2Department o...

Full description

Bibliographic Details
Main Authors: Hirakata T, Fujinami K, Watanabe K, Sasaki M, Noda T, Akiyama K
Format: Article
Language:English
Published: Dove Medical Press 2016-05-01
Series:Clinical Ophthalmology
Subjects:
Aflibercept
age-related macular degeneration
occult choroidal neovascularization
polypoidal choroidal vasculopathy
ranibizumab
resistance.
Online Access:https://www.dovepress.com/one-year-outcome-of-intravitreal-aflibercept-injection-for-age-related-peer-reviewed-article-OPTH

Internet

https://www.dovepress.com/one-year-outcome-of-intravitreal-aflibercept-injection-for-age-related-peer-reviewed-article-OPTH

Similar Items